ETFs: Drug Pricing Policy Shapes PPH Risks in 2026
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Stock indices are calculated by dedicated index providers using specified methodologies and governance processes. This article explains who does the work and why it matters.
16,076 articlesThe VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
As Reynolds prepares to report its 2026 earnings, investors are weighing growth catalysts, margin resilience, and pot...
A clear read of SERA’s Q1 2026 numbers and management commentary can shift an investor’s view of 2026. This guide bre...
Quadrant Private Wealth recently boosted its stake in Bluerock Private Real Estate Fund by about $13.6 million. This ...
Public records dumps grab headlines, but the real payoff is learning to money manage in a world of changing budgets a...
Broadcom is shifting from a broad tech portfolio to a focused AI chip powerhouse. If the company can turn custom AI c...
TONX reported healthy momentum in Q1 2026, but the real story lies in its growth engine. This article breaks down th...
Susquehanna lifts Plug Power’s price target to $3.75 as the Quantum Leap cost-cutting program shows early momentum. C...
Cisco surged about 17% after a record Q3 and stronger AI infrastructure orders, signaling a clear outperformance of p...
Lulu's LVLU is shaping its 2026 earnings story through stronger direct channels, smarter pricing, and inventory disci...
A growing wave of market voices warns that the flood of easy investing access can erode returns. Carlson says many in...
A new research note sets a bold 2027 price target for Procter & Gamble, arguing efficiency gains and steady demand co...